Delivery Order SPE2DB22D2206-SPE2DB25FJD16
- Not listed
- This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of TECVAYLI 153 mg/1.7 mL vials for delivery to the contractor's facility in Conshohocken, Pennsylvania. The contract has a ceiling value of $11,868.12 under firm fixed-price terms, with an ultimate completion date of September 11, 2025. This is a non-set-aside award, reflecting open competition in the procurement process. The delivery order is issued as a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, valued at $23,824.28, has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a $23,776 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TECVAYLI 153 MG/1.7 ML vials. Performance will take place in Conshohocken, Pennsylvania under a schedule contract vehicle over a two week period concluding on August 1, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will supply the requested pharmaceutical products to the Defense Logistics Agency, the logistics combat support agency within the Department of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $23,736.24, is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, that serves as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $23,824.28 contract is for the supply of the specialized pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a completion date of March 8, 2024. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,868.12, is for the delivery of the drug Tecvayli (153 mg/1.7 mL vial) to support military healthcare programs. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $26,577.85 contract is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product, with a period of performance through February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This contract is issued under an indefinite delivery contract (IDC) held by...
- This federal contract award, valued at $29,780.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- The Defense Logistics Agency awarded a $13,963.18 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Talvey 40 mg/ml vials. This firm fixed-price, competitively awarded contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order carries no set-aside designation and represents a relatively small-value transaction within the contractor's broader federal...
- The Defense Logistics Agency awarded a $27,926.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALVEY 40 mg/mL vials, with an ultimate completion date of September 2, 2025. This non-set-aside competitive award, issued on August 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD16Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TECVAYLI 153 mg/1.7 ml vials valued at $11,868.12 on July 29, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. TECVAYLI is a specialty pharmaceutical product reflecting the Defense Logistics Agency's ongoing procurement of specialized medical commodities to support military healthcare systems. This delivery order represents a task under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp has demonstrated its capability to meet diverse federal healthcare procurement requirements through consistent delivery of brand-name and generic medications, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains serving military and veteran healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 7/29/25 |